IGNOU MEDSE-046 Solved Assignment 2021-22
If you are looking for MEDSE-046 IGNOU Solved Assignment entitled 'Development: Issues and Perspectives*' you have come to the right place. Click on the image or the button below to get your verified and approved solved assignment PDF instantly on your email!
MEDSE-046: Development: Issues and Perspectives*
July 2021 and January 2022 Sessions
MEDSE-046 solved assignment is applicable for Post Graduate Diploma in Corporate Social Responsibility (PGDCSR), etc. programmes of IGNOU. The assignment you must submit depends on which exam you are planning to write. If you want to write term end exams in June 2022, you must write the July 2021 session assignment. If you want to write the exams in December 2022, you must write the January 2022 Session assignment. Assignments must be submitted before 31st March, 2022 (June exam) and 15th September 2022 (December exam) respectively. These dates may or may not be extended by the university hence it is best to submit it on time.
IGNOU Help Center recommends assignments from Gyaniversity Publications as all their assignments are verified by academic experts and teachers. Their assignments are not copy-pasted from IGNOU study material which makes them ideal for learning and getting good marks.
More Resources for MEDSE-046:
Get MEDSE-046 Solved Assignments, Guide Books and more
Exam Guide Book
Get guide books with predicted questions based on previous year question papers to pass easily!
Don't have time to write your assignment neatly? Get it written by experts and get free home delivery
Download IGNOU's official study material combined into a single PDF file absolutely free!
Project & Synopsis
Not all subjects have a project. If your subject does, click on learn more to get approved report & synopsis.
Download latest Assignment Question Papers for free in PDF format at the click of a button!
Need More Help?
To get additional help, please post your question in our student community forum. Our IGNOU Advisors will respond to you within 48 hours.